Yu gɛt kansa na yu skin? Lɛ wi lan bɔt Cutaneous T-Cell Lymphoma (CTCL)!

Yu de gɛt spat, blista, ɔ say dɛn we di kɔlɔ de chenj na yu skin we de it? Sɔmtɛm wi kin tink se dɛn tin ya na jɔs nɔmal tin dɛn we de apin na di skin, lɛk psoriasis ɔ ɛkzema. Bɔt, pan ɔl we i nɔ kin apin so ɔltɛm, sɔntin kin de we rili siriɔs biɛn dɛn sik ya. Na so i bi, wan kayn kansa we nɔ kin bɔku we kin afɛkt di skin, dɛn kɔl am Cutaneous T-Cell Lymphoma, ɔ CTCL. Lɛ wi tɔk bɔt am ditayli ɛn simpul wan tide.

Wetin na Kutan T-Sɛl Limfoma (CTCL)?

Fɔ tɔk am simpul wan, CTCL na wan kayn blɔd kansa we nɔ kin apin so ɔltɛm we kin afɛkt di skin, we na di big ɔgan na wi bɔdi. I rili de pat pan wan big grup fɔ kansa we dɛn kɔl Nɔn-Hɔdgkin Limfoma. i de stat insay wan kayn wayt bכdi sεl we dεn kכl Limfosayt, spεshal wan T limfosayt.

Bɔku pipul dɛn kin tink se kansa na sɔntin we wi fɔ fred. Bɔt bɔku pipul dɛn we gɛt CTCL kin wɛl afta dɛn dɔn trit dɛn ɛn dɛn kin kam bak to dɛn nɔmal layf. Bɔt, i nɔmal fɔ mek yu fil smɔl we yu kam fɔ no se yu gɛt kansa. Yu mɛdikal tim rɛdi fɔ ɛp yu insay dis tɛm.

Wetin na di men kayn CTCL?

Pan ɔl we sɔm kayn `(CTCL)` de, tu men kayn dɛn de we wi de si:

1. Maykɔsis Fɔngoyd (Mycosis Fungoides): .

• Dis na di kayn CTCL we dɛn kin gɛt mɔ, ɛn na wan kayn kansa we kin rili bad . Na lɛk af pan ɔl di CTCL pasɛnt dɛn de pan dis kayn.
• dis kin apin we di sεl dεm we dεn kכl ``T sεl dεm'' כ ``T limfosayt dεm'' bi kεnsar sεl dεm.
• Bɔt gud tin na dat, dɛn kansa sɛl ya kin skata smɔl pas di skin. Bɔt sɔntɛnde, sɔm pan dɛn sɛl ya kin travul go na yu limf no dɛm ɛn blɔd.
• we dεn kεnsar ``T-sεl dεm'' ya de sכkכt insay di bכdi, dכkta dεn kכl dεm ``Sézary sεl dεm''.

2. Di sik we dɛn kɔl Sézary Syndrome:

• Dis na wan kayn CTCL we de gro kwik kwik wan . Insay dis, yu kin si bɔku bɔku Sézary sɛl dɛn na yu skin ɛn blɔd .
• sכmtεm, di kכndyushכn `(Mycosis Fungoides)` kin bi siriכs εn divεlכp to `(Sézary Syndrome)`.
• Pipul wae gɛt dis sik kin gɛt bɔku bɔku kɔlɔ ɔlsay na dɛn skin.

Aw dis sik kin bɔku?

Cutaneous T-cell Lymphomas na rili rare . Fɔ ɛgzampul, na Amɛrika, dɛn se di kayn CTCL we dɛn kin gɛt pas ɔl, we dɛn kɔl Mycosis Fungoides, kin afɛkt lɛk wan pan ɛvri milyɔn pipul dɛn. Dis sik nɔ kin bɔku bak na Sri Lanka.

Wetin na di sayn dɛm fɔ (CTCL)?

Di sayn dɛm fɔ CTCL kin difrɛn frɔm wan pɔsin to ɔda pɔsin. Bɔt, na sɔm pan di sayn dɛm wae kin kam pan pɔrsin wae gɛt dis sik:

• Bɔmp ɔ blista we kin apin na di skin, sɔntɛnde i kin bɔs.
• Di ia we de lɔs.
• Skin di kɔlɔ we de skata ɔlsay na di bɔdi, itchy , lɛk rash.
• Di kɔlɔ we tan lɛk spat na di skin.
• Wan it we de it we de rayz, sɔm tɛm dɛn de i kin gɛt skel, na di say we di skin de.
• Di limf no dɛm we dɔn swel.
• di skin we de na di an ɛn di fut dɛn we de tik.

Imajin, wantɛm wantɛm wan smɔl rɛd ples de apia na yu an ɔ yu leg, we de gro smɔl smɔl, it, ɛn sɔntɛm i kin ivin bɔs ɛn tɔn to smɔl smɔl blista dɛn. Ɔ yu ia kin bigin fɔ fɔdɔm na say dɛn fɔ natin. If yu si sɔntin lɛk dis, nɔ jɔs ignore am.

Wetin na di tin dɛn we kin mek pɔsin gɛt (CTCL)?

infakt, wetin de apin insay `(Cutaneous T-cell Lymphoma)` na dat wi `(T lymphocytes)` sεl dεm de mכt (`mutate`) εn bi kεnsar sεl dεm we de divayd we dεn nכ de kכntro. Dɔktɔ dɛn stil nɔ no bɛtɛ bɛtɛ wan wetin mek `(CTCL)` de divɛlɔp , ɔr wetin mek sɔm pipul dɛn kin gɛt am mɔ. Bɔt tu tin dɛn de we dɛn kin tink se go ɛp:

1. Jεnεtik vεryכnt / mכtεshכn: Risach dεm dεn fכnshכn se chenj dεm na sכm jin dεm kin mek dis kכndyushכn. Dat min se, smɔl chenj dɛn we de apin na sɔm pan di jin dɛn na wi bɔdi kin mek dɛn sɛl dɛn ya tɔn to kansa sɛl dɛn .

2. Infεkshכn: We yu gεt infεkshכn, yu imyun sistεm kin rili aktif. fכ ansa dis, yu bon mכro de bigin fכ mek mכr limfosayt dεm. I tan lɛk faktri we de ramp ɔp prodakshɔn. We yu de wok so fast, sɔntɛnde mistek kin apin. dεn kכl dεn mistek dεm ya DNA mכtεshכn we de afekt di ki jin dεm na di limfosayt dεm. As tɛm de go, dis kin mek pɔsin gɛt lymphoma.

Wetin na di risk factor dɛm fɔ divɛlɔp (CTCL)?

Sɔm pipul dɛn kin gɛt mɔ chans fɔ gɛt `(Cutaneous T-cell Lymphoma)`. Dɛn na:

• Fɔ bi blak pɔsin. (Pan ɔl we dis na tin we sayɛnsman dɛn dɔn fɛn, dɛn nid fɔ stɔdi mɔ fɔ no aw i de afɛkt kɔntri dɛn lɛk wi yon.)
• Bikɔs i dɔn pas 50 ia.
• Di imyun sistɛm we wik.
• Fɔ bi man.

Nɔto ɔlman no se dɛn tin ya de, bɔt di pɔynt na dat di prɔblɛm kin pas smɔl.

Aw dɛn kin no CTCL?

If yu sɔspɛkt se yu gɛt CTCL, yu dɔktɔ go tek yu mɛdikal istri fɔs ɛn du yu bɔdi ɛgzam. Dɛn go pe atɛnshɔn mɔ to di spat ɛn plek dɛn we de na yu skin. Dɛn go aks bɔt yu sik dɛn ɛn aks bɔt ɛni mɛrɛsin we yu bin dɔn gɛt trade.

Test dɛn fɔ no if pɔsin gɛt di sik

fכ kכnfכm di diagnosis fכ `(Cutaneous T-cell Lymphoma)`, di dכkta go nid fכ du sεvεra tεst dεm. Di men wan dɛn na:

• Blɔd tɛst: Chɛk fɔ di Sézary sɛl dɛn ɛn ɔda tin dɛn we nɔ fayn na di blɔd.
• Imej tɛst: Dɛn kin yuz tɛst lɛk CT skan ɔ PET skan fɔ si if di kansa dɔn skata to ɔda pat dɛn na di bɔdi.
• limf node bayɔpsi: Dɛn kin tek smɔl sampul frɔm wan limf node we dɔn swel ɛn chɛk am.
• Skin biopsy: Dɛn kin tek smɔl pat pan di skin frɔm di say we di sik afɛkt ɛn chɛk am ɔnda maykroskɔp fɔ si if kansa sɛl dɛn de. Dis na di men tɛst fɔ no CTCL.

Stej dɛm fɔ CTCL

Dɔktɔ dɛn kin yuz difrɛn we dɛn fɔ klas, fɔ no if pɔsin gɛt kansa, ɛn fɔ plan fɔ trit pɔsin we gɛt kansa. di mכst kכmכn mεtכd we dεn yuz fכ no di stej dεm fכ CTCL na di TNM klasifikasiכn sistεm . Dis sistɛm de diskraib:

• T (Primary Tumor): Usay di kansa fɔs bigin ɛn aw fa i dɔn skata na di skin.
• N (Nearby Lymph Nodes): If di kansa dɔn spre to di limf no dɛm we de nia.
• M (Mεtastas): If di kεnsar dεn dכn spre to fa fa pat dεm na di bכdi (mεtastas).

dis (TNM) sistεm de yuz nכmba εn lεta dεm fכ no di εksakכt stej fכ yu (Cutaneous T-cell Lymphoma). Dis kin tranga smɔl, so yu dɔktɔ go ɛksplen dis to yu.

Aw dɛn kin trit CTCL?

Laki, sɔm we dɛn de fɔ trit CTCL. Di bɛst tritmɛnt de dipen pan yu kɔndishɔn.

• Stɛroyd krim ɔ ɔntmɛnt: Dɛn tin ya kin ɛp fɔ kɔntrol di sik dɛn we de apin na di skin.
• Layt tɛrapi (Fototherapy): Dɛn kin put spɛshal kayn layt rayt pan di skin fɔ pwɛl di kansa sɛl dɛn.
• Ekstrakɔpɔral Fɔtofɛrɛsis (ECP): Dis na tritmɛnt we kɔmpleks smɔl. Fɔ tɔk am simpul wan, dɛn kin tek sɔm pan yu blɔd, miks am wit spɛshal mɛrɛsin, put am na ɔltra vayolɛt layt, dɔn dɛn kin put am bak na yu bɔdi. Dis kin ɛp fɔ kɔntrol di kansa sɛl dɛn.
• Radieshɔn tɛrapi: Dɛn kin yuz rayt we gɛt bɔku ɛnaji fɔ pwɛl di kansa sɛl dɛn.
• Immunotherapy: I de mek yu yon imyun sistɛm fɔ fɛt di kansa sɛl dɛn.
• Kimotɛrapi: .Dɛn kin gi dɛn mɛrɛsin dɛn we de kil di kansa sɛl dɛn. Dɛn kin gi dis as krim, pil, ɔ injɛkshɔn.

Mɛmba se, no wan saiz tritmɛnt nɔ de. Yu dɔktɔ go tɛl yu us tritmɛnt opshɔn fɔ yu sik.

Yu tink se dɛn kin mek dɛn nɔ gɛt CTCL?

Bikɔs bɔrku pipul dɛm wae gɛt CTCL nɔr gɛt ɛni risk factor wae dɛn kin modify, natin nɔr de fɔ rili du fɔ mek yu nɔr gɛt am . Bɔt di wan dɛn we de stɔdi bɔt dis stil de stɔdi wetin mek dɛn tin ya kin apin.

Aw a go ridyus di prɔblɛm we a gɛt?

Pan ɔl we yu nɔ go ebul fɔ mek yu nɔ gɛt Cutaneous T-cell Lymphoma, we yu gɛt wik imyun sistɛm kin mek yu gɛt ɔl kayn kansa, nɔto jɔs CTCL. So, na sɔm tin dɛn ya yu kin du fɔ mek yu imyun sistɛm strɔng:

• It bɔku frut ɛn vɛjitebul dɛn.
• Ɛksesaiz ɔltɛm .
• Gɛt gud, slip fayn.
• Limit fɔ drink rɔm.
• Mek yu gɛt wɛlbɔdi wet fɔ yu.
• Kɔntrol strɛs tru we dɛn lɛk fɔ tink gud wan.
• Gɛt di vaysin dɛn we yu nid.
• If yu de smok, tray fɔ stɔp.
• Wash yu an ɔltɛm.

Wetin na di prɔgnosis fɔ pipul dɛm wae gɛt CTCL?

Bɔku pan di kayn CTCL dɛn kin rili smɔl ɛn nɔ kin rili mek pɔsin in layf de pan denja . Bɔt sɔm pipul dɛn kin gɛt siriɔs kayn sik. Pan ɔl we dɔktɔ dɛn nɔ kin ebul fɔ mɛn CTCL ɔltogɛda, tritmɛnt kin ɛp fɔ kɔntrol di sayn dɛm.

Bɔt lɛk ɔl di kansa dɛn, CTCL kin kil pɔsin we i dɔn go bifo. Di kwik we yu bigin fɔ tek tritmɛnt, na di mɔ yu ɔl chans fɔ wɛl . Na dat mek i rili impɔtant fɔ tɛl dɔktɔ jɔs afta yu notis ɛni chenj na yu skin.

Wetin na di sɔvayv rɛt fɔ (CTCL)?

90% pan di pipul dεm we gεt εli stej (stej I כ II) CTCL de liv fכ 10 ia. Dis min se nayn pan ɔl tɛn pipul dɛm wae gɛt dis sik stil de alayv afta 10 ia. di 10 ia sכvayv rεt fכ pipul dεm we gεt advans stej (stej III כ IV) CTCL na bכt 53%.

Impɔtant: Di nɔmba fɔ pipul dɛn we nɔ day na jɔs ɛstimat. Dɛn nɔr kin tɛl yu ustɛm yu go liv ɔr aw yu go du tritmɛnt. Aks yu dɔktɔ fɔ no mɔ bɔt dis.

Aw a kin kia fɔ misɛf?

Bikɔs Cutaneous T-cell Lymphoma kin afɛkt yu skin, i kin mek yu skin it, dray, ɛn flay. Pan ɔl we tritmɛnt kin kɔntrol aw di kansa de gro ɛn ridyus di sayn dɛm, sɔm tritmɛnt kin mek yu skin we dɔn ɔlrɛdi sɛnsitiv nɔ fil fayn. Dɛn advays ya kin ɛp:

• Kip yu skin wet: Put krim ɔ ɔntmɛnt pan yu skin afta yu dɔn was ɔ wet fɔ mek i kɔntinyu fɔ wet. I nɔ bad fɔ put di krim bak ɔl di de ɛn bifo yu go slip. Dis nɔ de jɔs protɛkt yu skin, bɔt i de mek yu skin nɔ dray ɛn nɔ de kɔmɔt fayn, i de kɔntrol yu skin, ɛn i de ɛp fɔ protɛkt yu skin frɔm infɛkshɔn.
• Protekt yu skin frɔm iritashɔn: We yu gɛt CTCL, yu skin kin rili sɛnsitiv. Ivin tin dɛn lɛk fɔ go na do na di san, fɔ yuz sɔm ditajɛn ɛn sop dɛn, ɛn fɔ wɛr sɔm kayn klos kin mek yu skin wam. Pik ditajɛn ɛn bɔdi was we nɔ gɛt ad sɛnt. Wear klos we de protɛkt yu skin frɔm di san, ɛn put sanskrin we yu de go na do. Wear klos we nɔ tay ɛn we go mek yu skin ebul fɔ blo.
• Nɔ skrach di it: Fɔ bɔku pipul dɛn, we dɛn de it ɔltɛm na siriɔs prɔblɛm we kin afɛkt dɛn kwaliti fɔ liv. If yu skrach, i kin mek di skin vɛks, we kin mek yu gɛt infɛkshɔn ɛn baktri dɛn kin kam insay di skin. Kol kɔmprɛs (lɛk ays pak, bag dɛn we gɛt frɔzɛn vɛjitebul), ɔtmil bat, ɛn antihistamin kin ɛp fɔ mek yu nɔ it.

Ustɛm a fɔ go to mi dɔktɔ?

Yu dɔktɔ go want fɔ chɛk yu ɔltɛm. Aks am ɔmɔs tɛm yu fɔ kam insay fɔ tɛst blɔd ɔ fɔ tɛst yu skin.

If na so i bi, mek shɔ se yu go to yu dɔktɔ:

• If yu notis ɛni nyu chenj na yu skin.
• If yu tink se yu gɛt infɛkshɔn na yu skin.
• If di fiva go ɔp pas 100.4 digri F (38 digri sɛlshiɔs).

Na kɔmɔn tin fɔ tink bɔt rash ɔ diskɔlɔreshɔn as nɔmal skin kɔndishɔn. I at bak fɔ biliv se wan kayn kansa we nɔ kin bɔku kin bi di kɔz. Bɔt i impɔtant fɔ tɛl yu dɔktɔ if yu notis ɛni chenj na yu skin . Dɔn dɛn kin no wetin de mek dɛn gɛt am. Sɔntɛm i nɔ kin bi kansa. Bɔt if na so i bi, tritmɛnt na di men tin. Di kwik we yu bigin fɔ tek tritmɛnt, na di mɔ yu go gɛt chans fɔ wɛl.

Fɔ dɔn, mɛsej we yu kin kɛr go na os:

Pan ɔl we Cutaneous T-Cell Lymphoma na kansa we nɔ kin bɔku na di skin, i impɔtant fɔ no bɔt am. If yu notis ɛni chenj we nɔ kɔmɔn na yu skin, yu de it ɔltɛm, ɔ yu notis wan spat we nɔ de wɛl, nɔ ignore am. Go to dɔktɔ wantɛm wantɛm. If yu no ɛn trit am kwik, yu kin ebul fɔ mɛn dis sik fayn fayn wan ɛn liv nɔrmal layf. Nɔ wɔri, nɔto yu wan de. Dɔktɔ ɛn wɛlbɔdi tim dɛn de fɔ ɛp yu.

` CTCL, Skin Kansa, Mycosis Fungoides, Sézary Syndrome, Limfoma, Skin Simptom, Kansa Tritmɛnt